penicillin v has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HERMANSKY, M; HEROLD, M; SMAHEL, O; VLCEK, V | 1 |
| Costa, MA; Martins, CA; Nucci, M; Velasco, E | 1 |
| Botek, R; Grausova, S; Grey, E; Koren, P; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Lacka, J; Oravcova, E; Rusnakova, V; Sorkovska, D; Spanik, S; Stopkova, K; Studena, M; Svec, J; Trupl, J | 1 |
| Foltinova, A; Kaiserova, E; Kiskova, M; Kovacicova, G; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Trupl, J; West, D | 1 |
3 trial(s) available for penicillin v and Neoplasms
| Article | Year |
|---|---|
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients.
Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillin V; Prospective Studies | 1995 |
Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacteremia; Bone Marrow Transplantation; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pefloxacin; Penicillin V; Regression Analysis; Streptococcal Infections | 1994 |
Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Child; Colistin; Fluconazole; Fungemia; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Ofloxacin; Penicillin V; Penicillins; Retrospective Studies; Risk Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
2 other study(ies) available for penicillin v and Neoplasms
| Article | Year |
|---|---|
[Effect of ascorbic acid on the absorption of potassium salts of phenoxymethylpenicillin. (Considerations on a new peroral penicillin preparation "fenaskopen")].
Topics: Ascorbic Acid; Neoplasms; Penicillin V; Penicillins; Potassium; Salts | 1960 |
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Drug Therapy, Combination; Humans; Incidence; Leukemia; Neoplasms; Ofloxacin; Penicillin Resistance; Penicillin V; Penicillins; Retrospective Studies; Risk Factors; Streptococcal Infections; Treatment Outcome; Vancomycin | 1997 |